DHR - Danaher Corporation
NEXT EARNINGS:
Apr 28, 2026
EPS Est: $1.94
|
Rev Est: $6.0B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$252.33
DETAILS
HIGH:
$270.00
LOW:
$220.00
MEDIAN:
$254.00
CONSENSUS:
$252.33
UPSIDE:
20.62%
Market Cap:
147.88B
Volume:
2,150,872
Avg Volume:
3,841,805
52 Week Range:
171-242.8
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
0.96
Last Dividend:
$1.28
Exchange:
NYSE
Country:
US
Employees:
61,000
IPO Date:
1978-12-29
EPS (TTM):
5.07
P/E Ratio:
44.80
Revenue (TTM):
24.57B
Total Assets:
83.46B
Total Debt:
18.42B
Cash & Equiv:
4.62B
Rev Growth (5Y):
2.0%
EPS Growth (5Y):
0.4%
FCF Growth (5Y):
-0.6%
ROCE:
5.9%
Debt/Equity:
0.35
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-28 | $2.23 | $2.16 | +3.2% | $6.8B | $6.8B | +0.4% |
| 2025-10-21 | $1.89 | $1.72 | +9.9% | $6.1B | $6.0B | +0.9% |
| 2025-07-22 | $1.80 | $1.64 | +9.8% | $5.9B | $5.8B | +1.7% |
| 2025-04-22 | $1.88 | $1.63 | +15.3% | $5.7B | $5.6B | +3.0% |
| 2025-01-29 | $2.14 | $2.14 | 0.0% | $6.5B | $6.4B | +1.4% |
| 2024-10-22 | $1.71 | $1.57 | +8.9% | $5.8B | $5.6B | +3.8% |
| 2024-07-23 | $1.72 | $1.57 | +9.6% | $5.7B | $5.6B | +2.8% |
| 2024-04-23 | $1.92 | $1.72 | +11.6% | $5.8B | $5.6B | +3.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.57B | 23.88B | 23.89B | 26.64B | 29.45B | 22.28B | 17.91B | 17.05B | 18.33B | 16.88B | 14.43B | 19.91B |
| Net Income | 3.61B | 3.90B | 4.76B | 7.21B | 6.43B | 3.65B | 2.56B | 2.65B | 2.49B | 2.55B | 2.60B | 2.60B |
| EPS | 5.07 | 5.33 | 6.44 | 9.80 | 8.77 | 4.97 | 3.48 | 3.78 | 3.58 | 3.69 | 4.81 | 3.70 |
| Total Assets | 83.46B | 77.54B | 84.49B | 84.35B | 83.18B | 76.16B | 62.08B | 47.83B | 46.65B | 45.30B | 48.22B | 36.99B |
| Total Debt | 18.42B | 17.15B | 19.54B | 20.62B | 23.27B | 22.18B | 22.53B | 9.74B | 10.52B | 12.27B | 12.87B | 3.47B |
| Cash & Equivalents | 4.62B | 2.08B | 5.86B | 6.00B | 2.59B | 6.04B | 19.91B | 787.80M | 630.30M | 963.70M | 790.80M | 3.01B |
| Operating Cash Flow | 6.42B | 6.69B | 7.16B | 8.52B | 8.36B | 6.21B | 3.95B | 4.02B | 3.48B | 3.52B | 3.80B | 3.76B |
| Free Cash Flow | 5.26B | 5.30B | 5.78B | 7.37B | 7.06B | 5.42B | 3.32B | 3.44B | 2.91B | 2.93B | 3.29B | 3.29B |
| FCF per Share | 7.44 | 7.24 | 7.85 | 10.16 | 9.89 | 7.67 | 4.64 | 4.91 | 4.18 | 4.24 | 4.71 | 4.69 |
| Book Value | 52.53B | 49.54B | 53.49B | 50.08B | 45.17B | 39.77B | 30.27B | 28.21B | 26.36B | 23.00B | 23.69B | 23.38B |
| Cash & ST Investments | 4.62B | 2.08B | 5.86B | 6.00B | 2.59B | 6.04B | 19.91B | 787.80M | 630.30M | 963.70M | 790.80M | 3.01B |
| ROC Equity | 0.07 | 0.08 | 0.09 | 0.14 | 0.14 | 0.09 | 0.08 | 0.09 | 0.09 | 0.11 | 0.11 | 0.11 |